Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

ReThink Pharmaceuticals

ReThink Pharmaceuticals
2014 FOUNDED
PRIVATE STATUS
Accelerator/Inc LATEST DEAL TYPE
$5K LATEST DEAL AMOUNT
1 INVESTORS
Description

Owner and operator of a biotechnology company. The company works in the field of drug re-purposing by developing a distinct algorithm based on evolutionary genomics.

Ownership Status
Privately Held (backing)
Financing Status
Accelerator/Incubator Backed
Primary Industry
Biotechnology
Other Industries
Drug Delivery
Discovery Tools (Healthcare)
Primary Office
  • Aluf Kalman Magen 3
  • Tel Aviv 6107075
  • Israel
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore ReThink Pharmaceuticals’s full profile, request a free trial.

ReThink Pharmaceuticals Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
1. Accelerator/Incubator 24-Jun-2015 $5K 000 Completed Startup
To view this company’s complete deal history including valuation and funding, request access »

ReThink Pharmaceuticals Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
MassChallenge Accelerator/Incubator 000 0000 000000 0

ReThink Pharmaceuticals Executive Team (5)

Name Title Board
Seat
Contact
Info
Etty Amir Ph.D Co-Founder & Chief Executive Officer
Guy Seemann Co-Founder & Chief Operating Officer
Yuval Tabach Co-Founder & Chief Scientist
Dmitry Shvartsman Ph.D Co-Founder & Scientific Adviser

1 Former Executive

You’re viewing 4 of 5 executives. Get the full list »